Muhamad Sajjad Sadiq, et al. “Effectiveness of SGLT2 Inhibitor (Empagliflozin) in Reduction of Albuminuria in Type 2 Diabetics”. Pioneer Journal of Biostatistics and Medical Research, vol. 1, no. 4, May 2024, pp. 26-38, https://doi.org/10.61171/2av4gt96.